Designing and Synthesis of an Anti-Candida parapsilosis Thymoquinone Lipid Formulation
Open Access
- 26 December 2023
- journal article
- research article
- Published by Brieflands in Jundishapur Journal of Microbiology
- Vol. 16 (10)
Abstract
Background: Candida parapsilosis complex, as an opportunistic pathogen, can cause various infections, especially in immunocompromised patients. Objectives: This study investigated a novel thymoquinone-liposomal nanoparticle to increase the stability of thymoquinone with antifungal effects against C. parapsilosis isolates. Methods: The thymoquinone was encapsulated in liposomal nanoparticles using a thin-film hydration technique and then analyzed by transmission electron microscopy (TEM), particle size, zeta potential, and UV-visible spectrophotometer. Also, the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) assay was used on peripheral blood mononuclear cells (PBMCs) for cell metabolic activity. The antifungal activity of thymoquinone-liposomal nanoparticle against 15 clinical isolates of C. parapsilosis and the reference strain was examined based on the M27-A3 guideline. Results: The synthesized thymoquinone-liposomal nanoparticle was approved by the TEM, particle size, zeta potential, and UV-Vis. The thymoquinone-liposomal nanoparticle showed no toxic effect on PBMCs following the MTT assay. The minimum inhibitory concentration (MIC) range of free thymoquinone and liposomal formulations with inhibitory effects on Candida isolates was 50 to 6.25 and 150 to 18.75 µg/mL, respectively. The MIC50 and MIC90 values of free thymoquinone and thymoquinone-liposomal nanoparticle were 25 and 50, and 75 and 150 µg/mL. Conclusions: The synthesized thymoquinone-liposomal nanoparticle shows significant antifungal activity against C. parapsilosis isolates compared to free thymoquinone. However, because of its hydrophilicity and hydrophobicity, biocompatibility, particle size, non-toxic effect, and higher cell viability, the thymoquinone-liposomal nanoparticle is a more effective approach for treating fungal infections.Keywords
This publication has 24 references indexed in Scilit:
- Antifungal Effects of Voriconazole-Loaded Nano-Liposome on Fluconazole - Resistant Clinical Isolates of Candida albicans , Biological Activity and ERG11, CDR1, and CDR2 Gene ExpressionASSAY and Drug Development Technologies, 2021
- Antifungal Activity of Curcuminoids and Difluorinated Curcumin Against Clinical Isolates of Candida Species2021
- Combinatorial therapy of Thymoquinone and Emodin synergistically enhances apoptosis, attenuates cell migration and reduces stemness efficiently in breast cancerBiochimica et Biophysica Acta (BBA) - General Subjects, 2020
- Fungicidal effect of thymoquinone involves generation of oxidative stress in Candida glabrataMicrobiological Research, 2017
- Thymoquinone Ameliorates Cadmium-Induced Nephrotoxicity, Apoptosis, and Oxidative Stress in Rats is Based on its Anti-Apoptotic and Anti-Oxidant PropertiesBiological Trace Element Research, 2015
- Liposomal thymoquinone effectively combats fluconazole-resistant Candida albicans in a murine modelInternational Journal of Biological Macromolecules, 2015
- Synthesis, morphology and antifungal activity of nano-particulated amphotericin-B, ketoconazole and thymoquinone againstCandida albicansyeasts andCandidabiofilmJournal of Environmental Science and Health, Part A, 2015
- Thymoquinone inhibits cell proliferation through regulation of G1/S phase cell cycle transition in N-nitrosodiethylamine-induced experimental rat hepatocellular carcinomaToxicology Letters, 2013
- A review on therapeutic potential of Nigella sativa: A miracle herbAsian Pacific Journal of Tropical Biomedicine, 2013
- Zein: the industrial protein from cornIndustrial Crops and Products, 2001